Washington: Artificial pancreas improved glucose levels and significantly reduced the risk of hypoglycemia as compared with diabetes treatment using an insulin pump, IRCM researchers have found.Their results can have a great impact on the treatment of type 1 diabetes by accelerating the development of the external artificial pancreas.The artificial pancreas is an automated system that simulates the normal pancreas by continuously adapting insulin delivery based on changes in glucose levels. The dual-hormone artificial pancreas tested at the IRCM controls glucose levels by automatically delivering insulin and glucagon, if necessary, based on continuous glucose monitor (CGM) readings and guided by an advanced algorithm.Endocrinologist Dr. Remi Rabasa-Lhoret led the researchers.
John Kerry and PM Modi`s high level meet
Salman`s `Kick` crosses Rs 100-crore mark
Exclusive interview with Natwar Singh
Trilokpuri mishap: E-rickshaw driver arrested